Estadísticas
Número total de visitas
| Visualizaciones | |
|---|---|
| Three-year outcomes in a randomized single-blind controlled trial of intravitreal ranibizumab and oral supplementation with docosahexaenoic Acid and antioxidants for diabetic macular edema | 723 |
Visitas al mes
| enero 2026 | febrero 2026 | marzo 2026 | abril 2026 | mayo 2026 | junio 2026 | julio 2026 | |
|---|---|---|---|---|---|---|---|
| Three-year outcomes in a randomized single-blind controlled trial of intravitreal ranibizumab and oral supplementation with docosahexaenoic Acid and antioxidants for diabetic macular edema | 49 | 32 | 31 | 36 | 59 | 34 | 6 |
Visitas al fichero
| Visualizaciones | |
|---|---|
| articulo7JL.pdf | 242 |
Países con más visualizaciones
| Visualizaciones | |
|---|---|
| Estados Unidos | 242 |
| Alemania | 105 |
| Singapur | 90 |
| Irlanda | 75 |
| Hong Kong | 33 |
| Brasil | 21 |
| Reino Unido | 21 |
| España | 17 |
| Japón | 13 |
| Canadá | 12 |
Ciudades con más visualizaciones
| Visualizaciones | |
|---|---|
| Frankfurt am Main | 95 |
| Ashburn | 83 |
| Dublin | 75 |
| Hong Kong | 28 |
| Singapore | 23 |
| San Jose | 22 |
| Council Bluffs | 17 |
| London | 13 |
| Forest | 9 |
| El Monte | 6 |
